Thus, lower levels of adiponectin in the fetal circulation and in the placenta associated with maternal diabetes [85, 86, 139–141] may result from various alterations of the intrauterine environment of diabetes, but reduced levels of the proangiogenic adiponectin suggest that it will not contribute to placental hypervascularisation. Here, ADIPOQ is linked to diabetes mellitus.